Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopiform dermatitis.

J D Bos1

  • 1Department of Dermatology A0-235, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. j.d.bos@amc.uva.nl

The British Journal of Dermatology
|September 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.

The British journal of dermatology·2016
Same author

Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years.

The British journal of dermatology·2016
Same author

Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

The skin immune system Its cellular constituents and their interactions.

Immunology today·2014
Same author

Provoking factors, including chemicals, in Dutch patients with vitiligo.

The British journal of dermatology·2012
Same journal

Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

The British journal of dermatology·2026
Same journal

Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.

The British journal of dermatology·2026
Same journal

Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.

The British journal of dermatology·2026
Same journal

Mee's Lines.

The British journal of dermatology·2026
Same journal

Geographic diversity in top dermatology journal editorial boards.

The British journal of dermatology·2026
Same journal

Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.

The British journal of dermatology·2026
See all related articles

A new term, atopiform dermatitis, is proposed for non-atopic patients with atopic dermatitis-like symptoms. This distinction aids research and clarifies that allergen avoidance is unnecessary for atopiform dermatitis, unlike true atopic dermatitis.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Atopic dermatitis is a complex syndrome characterized by allergen-specific immunoglobulin E (IgE) production.
  • Dermatitis with atopic features can occur in patients without true atopy.
  • Current diagnostic criteria may not adequately differentiate these conditions.

Purpose of the Study:

  • To introduce and define the term 'atopiform dermatitis'.
  • To differentiate atopiform dermatitis from true atopic dermatitis.
  • To guide future research and clinical management.

Main Methods:

  • Conceptual proposal and definition of a new clinical term.
  • Review of characteristics of atopic dermatitis and related syndromes.
  • Analysis of immunological markers, specifically IgE.

Related Experiment Videos

Main Results:

  • Proposed 'atopiform dermatitis' for non-atopic individuals with similar symptoms.
  • Identified specific syndromes where atopiform dermatitis is a more fitting diagnosis.
  • Highlighted the absence of allergen-specific IgE in atopiform dermatitis.

Conclusions:

  • Distinguishing atopiform dermatitis from true atopic dermatitis will improve research clarity.
  • Atopiform dermatitis is a distinct clinical entity not requiring allergen avoidance.
  • This new classification supports targeted genetic, immunological, and therapeutic studies.